Back to search
FDAFDA · Food and drugs·Recall number D-160-2013

Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9

Published February 20, 2013 · Recall initiated: November 20, 2012

Summary

FDA records drug Class II recall D-160-2013, published February 20, 2013 and initiated November 20, 2012. Recalling firm: Upsher Smith Laboratories, Inc.; Status: Terminated; Reported quantity: 60 bottles; Lot: Lot #308198, Expiration Date is 03/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Test Requirements

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Upsher Smith Laboratories, Inc.
Distributor
FL, NJ.
Lot
Lot #308198, Expiration Date is 03/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9 recalled?

Yes. FDA published recall D-160-2013 on February 20, 2013. Reported hazard: Failed Dissolution Test Requirements

What should I do if I have this product?

Voluntary: Firm initiated · Telephone